Millennium Management
PRME icon

Millennium Management’s Prime Medicine PRME Stock Holding History

Millennium Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,335
Closed -$178K – 6243
2025
Q4 		$178K Sell
51,335
-1,367,128
-96% -$6.08M ﹤0.01% 5499
2025
Q3 		$7.86M Buy
1,418,463
+1,270,467
+858% +$5.16M ﹤0.01% 2637
2025
Q2 		$366K Sell
147,996
-1,631,949
-92% -$2.52M ﹤0.01% 5086
2025
Q1 		$3.54M Sell
1,779,945
-94,626
-5% -$241K ﹤0.01% 3209
2024
Q4 		$5.47M Sell
1,874,571
-323,669
-15% -$1.14M ﹤0.01% 2738
2024
Q3 		$8.51M Buy
2,198,240
+867,313
+65% +$4.02M ﹤0.01% 2342
2024
Q2 		$6.84M Buy
1,330,927
+895,610
+206% +$5.43M ﹤0.01% 2421
2024
Q1 		$3.05M Buy
435,317
+300,773
+224% +$2.28M ﹤0.01% 3347
2023
Q4 		$1.19M Buy
+134,544
New +$1.04M ﹤0.01% 4015
2023
Q3 		– Sell
-256,560
Closed -$3.76M – 6459
2023
Q2 		$3.76M Buy
256,560
+245,801
+2,285% +$3.43M ﹤0.01% 2921
2023
Q1 		$132K Buy
+10,759
New +$175K ﹤0.01% 5324

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Millennium Management's PRME Position: Q1 2026 in Review

Millennium Management sold out of Prime Medicine (PRME) in Q1 2026, closing a stake of 51,335 shares — an estimated $178K sold.

Millennium Management first reported a position in PRME in Q1 2023 and held it in 11 quarters. The position peaked at $8.51M in Q3 2024. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Millennium Management reported no remaining Prime Medicine position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 51,335 Prime Medicine shares in Q1 2026, an estimated $178K.
  • Millennium Management first reported a position in Prime Medicine in Q1 2023 and held it in 11 quarters.
  • Millennium Management's Prime Medicine position peaked at $8.51M in Q3 2024.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.